Related Experiment Video
Updated: Aug 16, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel
Augustine Koh Jing Jie1,2, Maytham Hussein2, Gauri G Rao3
1Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia.
Abstract:
Multidrug-resistant (MDR) Gram-negative pathogens remain an unmet public health threat. In recent times, increased rates of resistance have been reported not only to commonly used antibiotics, but also to the last-resort antibiotics, such as polymyxins. More worryingly, despite the current trends in resistance, there is a lack of new antibiotics in the drug-discovery pipeline. Hence, it is imperative that new strategies are developed to preserve the clinical efficacy of the current antibiotics, particularly the last-line agents. Combining conventional antibiotics such as polymyxins with non-antibiotics (or adjuvants), has emerged as a novel and effective strategy against otherwise untreatable MDR pathogens. This review explores the available literature detailing the latest polymyxin/non-antibiotic combinations, their mechanisms of action, and potential avenues to advance their clinical application.
Insights
New strategies combining polymyxins with non-antibiotics offer hope against multidrug-resistant (MDR) Gram-negative pathogens. This approach aims to preserve the effectiveness of last-resort antibiotics facing rising resistance.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Multidrug-resistant (MDR) Gram-negative pathogens pose a significant public health challenge.
- Increasing resistance to both common and last-resort antibiotics, like polymyxins, is a growing concern.
- There is a critical shortage of new antibiotics in the drug discovery pipeline.
Purpose of the Study:
- To review current literature on polymyxin/non-antibiotic combinations.
- To explore the mechanisms of action for these novel combinations.
- To identify pathways for advancing the clinical application of these strategies.
Main Methods:
- Literature review of existing studies on polymyxin and non-antibiotic combinations.
- Analysis of reported mechanisms of action.
- Evaluation of potential clinical applications and future research directions.
Main Results:
- Polymyxin/non-antibiotic combinations show promise as an effective strategy against MDR pathogens.
- These combinations can help overcome resistance to last-line antibiotics.
- Various non-antibiotic agents are being explored for synergistic effects with polymyxins.
Conclusions:
- Combining polymyxins with non-antibiotics is a viable strategy to combat MDR Gram-negative infections.
- Further research and clinical trials are needed to optimize and implement these combinations.
- This approach is crucial for preserving the efficacy of existing antibiotics and addressing the antibiotic resistance crisis.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Antibiotic Selection
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

